(Q47207523)

English

Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial).

scientific article published on 29 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial). (English)

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

obsessive-compulsive disorder

1 reference

based on heuristic

inferred from title

author name string

Mehdi Sayyah

1

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

Mohammad Sayyah

2

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

Hatam Boostani

3

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

Seyyed Mohammad Ghaffari

4

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

Abedin Hoseini

5

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

publication date

29 August 2012

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

Depression and Anxiety

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

29

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

850-854

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

10

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

Quality of life in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological management of treatment-resistant obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

An update on the pharmacological treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

5-HT1A receptor responsivity in anxiety disorders and depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Aripiprazole Augmentation of Serotonin Reuptake Inhibitors or Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.21996

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.21996

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/22933237

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47207523&oldid=1501665221"